No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

The S&P 500 gained 0.5% on Thursday, Jan. 23, reaching a record close as President Donald Trump pressed for lower oil prices ...

MRNA’s first problem is the lack of near-term catalysts beyond infectious disease vaccines. The stock often swings on disease outbreaks, such as H5N1 avian flu last year, but this is unlikely to ...

We recently compiled a list of the These 10 Companies Led Gains on Wednesday. In this article, we are going to take a look at ...

John Batchelor and I dive into the accelerating outbreak of avian flu across the U.S. and the hazard of raw milk.

A team of virologists, infectious disease specialists and pathobiologists affiliated with several institutions in China and the U.K. has found possible evidence that bird flu vaccinations are driving ...

H5N1 avian influenza continues to spread amid commercial and backyard poultry, and additional cases have been reported in domestic cats ...

Stocks closed solidly higher on Thursday for the fourth straight session as investor optimism about the Trump administration continues to run high.